| The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models L Shi, G Campbell, WD Jones, F Campagne, Z Wen, SJ Walker, Z Su, ... Nature biotechnology 28 (8), 827, 2010 | 892 | 2010 |
| Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial JR Westin, F Chu, M Zhang, LE Fayad, LW Kwak, N Fowler, J Romaguera, ... The lancet oncology 15 (1), 69-77, 2014 | 653 | 2014 |
| lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer Z Wang, B Yang, M Zhang, W Guo, Z Wu, Y Wang, L Jia, S Li, ... Cancer Cell 33 (4), 706-720. e9, 2018 | 436 | 2018 |
| Oncogenic BRAF (V600E) promotes stromal cell-mediated immunosuppression via induction of interleukin-1 in melanoma JS Khalili, S Liu, TG Rodríguez-Cruz, M Whittington, S Wardell, C Liu, ... Clinical Cancer Research 18 (19), 5329-5340, 2012 | 334 | 2012 |
| Reciprocal leukemia-stroma VCAM-1/VLA-4-dependent activation of NF-κB mediates chemoresistance R Jacamo, Y Chen, Z Wang, W Ma, M Zhang, EL Spaeth, Y Wang, ... Blood 123 (17), 2691-2702, 2014 | 328 | 2014 |
| Prognostic impact and targeting of CRM1 in acute myeloid leukemia K Kojima, SM Kornblau, V Ruvolo, A Dilip, S Duvvuri, RE Davis, M Zhang, ... Blood 121 (20), 4166-4174, 2013 | 249 | 2013 |
| A decade of toxicogenomic research and its contribution to toxicological science M Chen, M Zhang, J Borlak, W Tong Toxicological Sciences 130 (2), 217-228, 2012 | 179 | 2012 |
| Edge-based scoring and searching method for identifying condition-responsive protein–protein interaction sub-network Z Guo, Y Li, X Gong, C Yao, W Ma, D Wang, Y Li, J Zhu, M Zhang, D Yang, ... Bioinformatics 23 (16), 2121-2128, 2007 | 172 | 2007 |
| MICU1 drives glycolysis and chemoresistance in ovarian cancer PK Chakraborty, SB Mustafi, X Xiong, SKD Dwivedi, V Nesin, S Saha, ... Nature communications 8, 14634, 2017 | 148 | 2017 |
| Apparently low reproducibility of true differential expression discoveries in microarray studies M Zhang, C Yao, Z Guo, J Zou, L Zhang, H Xiao, D Wang, D Yang, ... Bioinformatics 24 (18), 2057-2063, 2008 | 143 | 2008 |
| Evaluating reproducibility of differential expression discoveries in microarray studies by considering correlated molecular changes M Zhang, L Zhang, J Zou, C Yao, H Xiao, Q Liu, J Wang, D Wang, C Wang, ... Bioinformatics 25 (13), 1662-1668, 2009 | 142 | 2009 |
| A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancer S Wu, R Rupaimoole, F Shen, S Pradeep, C Pecot, C Ivan, A Nagaraja, ... Nature Communication 7, 2016 | 140 | 2016 |
| HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genes R Mbofung, J McKenzie, S Malu, M Zhang, W Peng, C Liu, I Kuiatse, ... Nature Communication 8 (1), 451, 2017 | 135 | 2017 |
| Cross talk between follicular Th cells and tumor cells in human follicular lymphoma promotes immune evasion in the tumor microenvironment S Rawal, F Chu, M Zhang, HJ Park, D Nattamai, S Kannan, R Sharma, ... The Journal of Immunology 190 (12), 6681-6693, 2013 | 120 | 2013 |
| Systematic identification of non-coding pharmacogenomic landscape in cancer Y Wang, Z Wang, J Xu, J Li, S Li, M Zhang, D Yang Nature communications 9 (1), 3192, 2018 | 107 | 2018 |
| The effect of topoisomerase I inhibitors on the efficacy of T-cell-based cancer immunotherapy JA McKenzie, RM Mbofung, S Malu, M Zhang, E Ashkin, S Devi, ... JNCI: Journal of the National Cancer Institute 110 (7), 777-786, 2017 | 84 | 2017 |
| Pre-BCR signaling in precursor B-cell acute lymphoblastic leukemia regulates PI3K/AKT, FOXO1 and MYC, and can be targeted by SYK inhibition S Köhrer, O Havranek, F Seyfried, C Hurtz, G Coffey, E Kim, E Hacken, ... Leukemia 30 (6), 1246–1254, 2016 | 83 | 2016 |
| IGFBP2 regulates PD-L1 expression by activating the EGFR-STAT3 signaling pathway in malignant melanoma T Li, C Zhang, G Zhao, X Zhang, M Hao, S Hassan, M Zhang, H Zheng, ... Cancer letters 477, 19-30, 2020 | 66 | 2020 |
| Gaining confidence in biological interpretation of the microarray data: the functional consistence of the significant GO categories D Yang, Y Li, H Xiao, Q Liu, M Zhang, J Zhu, W Ma, C Yao, J Wang, ... Bioinformatics 24 (2), 265-271, 2007 | 65 | 2007 |
| Is toxicogenomics a more reliable and sensitive biomarker than conventional indicators from rats to predict drug-induced liver injury in humans? M Zhang, M Chen, W Tong Chemical research in toxicology 25 (1), 122-129, 2011 | 62 | 2011 |
